FDA Adverse Event Injury Summary report: N

CONFIDA BRECKER CURVE GUIDEWIRE

MDR report key: 22152259 · Received June 5, 2025

Report

Report Number
2025587-2025-04085
Event Type
Injury
Date Received
June 5, 2025
Date of Event
May 14, 2025
Report Date
July 10, 2025
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
DQX
PMA / PMN Number
K132623
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CONTINUATION OF D10: PRODUCT ID EVOLUTFX-26 (K060221); PRODUCT TYPE: 0195-HEART VALVES; IMPLANT DATE (B)(6) 2025; EXPLANT DATE SELECT PATIENT INFORMATION CANNOT BE INCLUDED IN THE REGULATORY REPORT DUE TO REGIONAL PRIVACY REGULATIONS. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

UPDATED DATA: B2. B5. H6. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

IT WAS REPORTED THAT DURING THE IMPLANT OF THIS TRANSCATHETER BIOPROSTHETIC VALVE, AFTER VALVE PLACEMENT, A DROP IN BLOOD PRESSURE WAS OBSERVED. PERCUTANEOUS CARDIOPULMONARY SUPPORT (PCPS) WAS INTRODUCED DUE TO THE HYPOTENSION AND THE HEMODYNAMICS STABILIZED. THE CAUSE OF THE HYPOTENSION WAS LIKELY DUE TO LOW FLOW LOW GRADIENT SEVERE AORTIC STENOSIS, WHERE THE BLOOD FLOW OUTPUT POST-VALVE PLACEMENT WAS INSUFFICIENT MAKING LEAFLET COAPTATION DIFFICULT. ADDITIONALLY, THE LEFT VENTRICLE GUIDEWIRE PRESSED AGAINST THE VALVE LEAFLETS. THIS LIKELY CAUSED AN INCREASE IN AORTIC REGURGITATION AND CONTRIBUTED TO THE HYPOTENSION.

Description of Event or Problem · 0

ADDITIONAL INFORMATION WAS RECEIVED THAT THE TYPE OF AORTIC REGURGITATION WAS CENTRAL AND THE SEVERITY WAS SEVERE. ONCE THE GUIDEWIR E WAS REMOVED, THE PATIENT'S SYMPTOMS IMPROVED. TREATMENT WAS NOT REQUIRED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
71466 CONFIDA BRECKER CURVE GUIDEWIRE WIRE, GUIDE, CATHETER DQX MEDTRONIC HEART VALVES DIVISION GWBC30

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Life Threatening| R SEE H11...